Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?

J Clin Oncol. 2022 Aug 1;40(22):2508. doi: 10.1200/JCO.22.00488. Epub 2022 May 12.

¹ Vincent Fallet, MD, Mateo Sanchis-Borja, MD, Department of Pneumology and Thoracic Oncology, Tenon Hospital, Assistance Publique Hôpitaux de Paris and GRC 4, Theranoscan, Sorbonne Université, Paris, France; Patrick R. Benusiglio, MD, Department of Genetics, Oncogenetics Consulting, Oncogenetics Functional Unit, Groupe Hospitalier Pitié-Salpêtrière APHP, Paris, France, Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 et SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Paris, France; and Jacques Cadranel, PhD, Department of Pneumology and Thoracic Oncology, Tenon Hospital, Assistance Publique Hôpitaux de Paris and GRC 4, Theranoscan, Sorbonne Université, Paris, France.

No abstract available

Publication types